157 related articles for article (PubMed ID: 8141565)
1. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.
Martin E; Stüben A; Görz A; Weller U; Bhakdi S
Antimicrob Agents Chemother; 1994 Jan; 38(1):13-22. PubMed ID: 8141565
[TBL] [Abstract][Full Text] [Related]
2. Uptake and killing of Candida by human peritoneal macrophages and amphotericin B.
Linde HJ; Stille W; Shah PM
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):79-84. PubMed ID: 8007745
[TBL] [Abstract][Full Text] [Related]
3. Bromelain is an accelerator of phagocytosis, respiratory burst and Killing of Candida albicans by human granulocytes and monocytes.
Brakebusch M; Wintergerst U; Petropoulou T; Notheis G; Husfeld L; Belohradsky BH; Adam D
Eur J Med Res; 2001 May; 6(5):193-200. PubMed ID: 11410400
[TBL] [Abstract][Full Text] [Related]
4. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
Ponce E; Pechère JC
Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
[TBL] [Abstract][Full Text] [Related]
5. Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5-fluorocytosine.
Richardson MD; Paton M; Shankland GS
Mycoses; 1991; 34(5-6):201-4. PubMed ID: 1795714
[TBL] [Abstract][Full Text] [Related]
6. Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes.
Raponi G; Ghezzi MC; Mancini C; Filadoro F
Antimicrob Agents Chemother; 1993 Sep; 37(9):1958-61. PubMed ID: 8239612
[TBL] [Abstract][Full Text] [Related]
7. Modulation of anti-Candida activity of human alveolar macrophages by interferon-gamma or interleukin-1-alpha.
Vecchiarelli A; Todisco T; Puliti M; Dottorini M; Bistoni F
Am J Respir Cell Mol Biol; 1989 Jul; 1(1):49-55. PubMed ID: 2516451
[TBL] [Abstract][Full Text] [Related]
8. Effect of cilofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils.
Richardson MD; Scott G; Shankland GS
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):22-6. PubMed ID: 1563379
[TBL] [Abstract][Full Text] [Related]
9. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
[TBL] [Abstract][Full Text] [Related]
10. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
Bistoni F; Vecchiarelli A; Mazzolla R; Puccetti P; Marconi P; Garaci E
Antimicrob Agents Chemother; 1985 Apr; 27(4):625-31. PubMed ID: 3890731
[TBL] [Abstract][Full Text] [Related]
11. Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leucocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions.
Thompson HL; Wilton JM
Clin Exp Immunol; 1992 Feb; 87(2):316-21. PubMed ID: 1310454
[TBL] [Abstract][Full Text] [Related]
12. Candida albicans Targets a Lipid Raft/Dectin-1 Platform to Enter Human Monocytes and Induce Antigen Specific T Cell Responses.
de Turris V; Teloni R; Chiani P; Bromuro C; Mariotti S; Pardini M; Nisini R; Torosantucci A; Gagliardi MC
PLoS One; 2015; 10(11):e0142531. PubMed ID: 26562838
[TBL] [Abstract][Full Text] [Related]
13. Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophages.
Allwinn R; Schaumann R; Shah PM
Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):163-7. PubMed ID: 8531506
[TBL] [Abstract][Full Text] [Related]
14. The release of TNF-alpha and IL-6 from human monocytes stimulated by filtrates of Candida albicans after treatment with amphotericin B.
Ghezzi MC; Raponi G; Filadoro F; Mancini C
J Antimicrob Chemother; 1994 May; 33(5):1039-43. PubMed ID: 8089051
[No Abstract] [Full Text] [Related]
15. Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus.
Roilides E; Anastasiou-Katsiardani A; Dimitriadou-Georgiadou A; Kadiltsoglou I; Tsaparidou S; Panteliadis C; Walsh TJ
J Infect Dis; 1998 Dec; 178(6):1734-42. PubMed ID: 9815227
[TBL] [Abstract][Full Text] [Related]
16. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
van Etten EW; van de Rhee NE; van Kampen KM; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 1991 Nov; 35(11):2275-81. PubMed ID: 1804000
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
18. Strong correlation between the antifungal effect of amphotericin B and its inhibitory action on germ-tube formation in a Candida albicans URA⁺ strain.
Guirao-Abad JP; González-Párraga P; Argüelles JC
Int Microbiol; 2015 Mar; 18(1):25-31. PubMed ID: 26415664
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans.
Vázquez N; Walsh TJ; Friedman D; Chanock SJ; Lyman CA
Infect Immun; 1998 Jan; 66(1):145-50. PubMed ID: 9423851
[TBL] [Abstract][Full Text] [Related]
20. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease.
Mpofu CM; Campbell BJ; Subramanian S; Marshall-Clarke S; Hart CA; Cross A; Roberts CL; McGoldrick A; Edwards SW; Rhodes JM
Gastroenterology; 2007 Nov; 133(5):1487-98. PubMed ID: 17919633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
